• An Appeal To The Global Health Community For A Tripartite Innovation: An "Essential Diagnostics List," "Health In All Policies," And "See-Through 21(St) Century Science And Ethics" 

      Dove, Edward S.; Barlas, I. Omer; Birch, Kean; Boehme, Catharina; Borda-Rodriguez, Alexander; Byne, William M.; Chaverneff, Florence; Coskun, Yavuz; Dahl, Marja-Liisa; Dereli, Turkay; Diwakar, Shyam; Elbeyli, Levent; Endrenyi, Laszlo; Eroglu-Kesim, Belgin; Ferguson, Lynnette R.; Gungor, Kivanc; Gursoy, Ulvi; Hekim, Nezih; Huzair, Farah; Kaushik, Kabeer; Kickbusch, Ilona; Kiroglu, Olcay; Kolker, Eugene; Kononen, Eija; Lin, Biaoyang; Llerena, Adrian; Malhan, Faruk; Nair, Bipin; Patrinos, George P.; Sardas, Semra; Sert, Ozlem; Srivastava, Sanjeeva; Steuten, Lotte M. G.; Toraman, Cengiz; Vayena, Effy; Wang, Wei; Warnich, Louise; Ozdemir, Vural (Mary Ann Liebert, Inc, 2015)
      Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and nanotechnology, are emerging as companion tests to innovative medicines. In this Opinion, we present the rationale for ...